| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
March 02, 2011 |
|
|
| |
|
|
| |
|
|
|
IBC Asia (S) Pte Ltd, Tokyo, Japan
7-8 July 2011
Clinical Trials Japan takes place at a time when government and industry initiatives are yielding results to enhance clinical development. It will bring together experts in clinical development, top clinicians and investigators from global and local pharmas, medical device companies, biotechs, CROs and research institutes in and outside Japan. THEMES TO BE DISCUSSED AT THE CONFERENCE |
Regulatory Reforms to Support Clinical Development in Japan | Understanding Key Challenges in Japanese Trials | Adapting Global Clinical Trial Strategies | Application of Global Best Practices and Experience | Key Barriers to Optimizing Speed and Cost Effectiveness in Japan | Expediting trials through Collaboration with External Stakeholders | Future growth and Opportunities in Clinical Trials in Japan |
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Asia (S) Pte Ltd |
|
|
Invited Speakers:
|
|
Speakers from the following fields have been invited to speak: 1. Global Strategy for Clinical Trials2. Site Selection in Conducting Global Trials3. Recognizing and Meeting Efficacy and Dosage Differences for the Japanese Market4. Effective Clinical Management Strategy in Japan5. Designing Successful Protocols for Japan6. Effective Patient Recruitment Strategies7. Overcoming the Language Barrier
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
05/03/2011
|
|
|
|
|
|
|
|
Registration:
|
|
www.clinicaltrials-japan.com
|
|
|
E-mail:
|
|
rita.parasurum@ibcasia.com.sg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|